Literature DB >> 10814616

Management of cardiogenic shock complicating acute myocardial infarction: towards evidence based medical practice.

S G Williams1, D J Wright, L B Tan.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10814616      PMCID： PMC1760870          DOI： 10.1136/heart.83.6.621

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  73 in total

1.  Efficacy of invasive strategy for the management of acute myocardial infarction complicated by cardiogenic shock.

Authors:  N Pérez-Castellano; E García; J A Serrano; J Elízaga; J Soriano; M Abeytua; J Botas; R Rubio; E López de Sá; J L López-Sendón; J L Delcán
Journal:  Am J Cardiol       Date:  1999-04-01       Impact factor: 2.778

2.  New therapeutic approaches to acute myocardial infardial infarction (MI) and its size: the surgical approach.

Authors:  W J Keon
Journal:  Adv Exp Med Biol       Date:  1977       Impact factor: 2.622

Review 3.  Prevention of cardiogenic shock.

Authors:  J S Geddes; A A Adgey; J F Pantridge
Journal:  Am Heart J       Date:  1980-02       Impact factor: 4.749

4.  Temporal trends in cardiogenic shock complicating acute myocardial infarction.

Authors:  R J Goldberg; N A Samad; J Yarzebski; J Gurwitz; C Bigelow; J M Gore
Journal:  N Engl J Med       Date:  1999-04-15       Impact factor: 91.245

5.  Treatment of cardiogenic shock in myocardial infarction by intraaortic balloon counterpulsation surgery.

Authors:  S A Johnson; P J Scanlon; H S Loeb; J M Moran; R Pifarre; R M Gunnar
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

6.  Cardiogenic shock following acute myocardial infarction; late functional results after emergency cardiac surgery.

Authors:  V A Subramanian; A J Roberts; M J Zema; R M Abel; J C McCabe; E Hoover; P Kligfield; W A Gay
Journal:  N Y State J Med       Date:  1980-05

7.  Limitation of myocardial infarct size after primary angioplasty: is a higher patency the only mechanism?

Authors:  J P Ottervanger; A Liem; M J de Boer; A W van 't Hof; H Suryapranata; J C Hoorntje; F Zijlstra
Journal:  Am Heart J       Date:  1999-06       Impact factor: 4.749

8.  Primary angioplasty for cardiogenic shock complicating acute myocardial infarction.

Authors:  R Calton; T M Jaison; T David
Journal:  Indian Heart J       Date:  1999 Jan-Feb

9.  Arterial counterpulsation in severe refractory heart failure complicating acute myocardial infarction.

Authors:  M F O'Rourke; N Sammel; V P Chang
Journal:  Br Heart J       Date:  1979-03

10.  Intraaortic balloon counterpulsation with and without reperfusion for myocardial infarction shock.

Authors:  M A DeWood; R N Notske; G R Hensley; J P Shields; W P O'Grady; J Spores; M Goldman; J H Ganji
Journal:  Circulation       Date:  1980-06       Impact factor: 29.690
View more
  4 in total

1.  Troglitazone decreases collagen accumulation in prediabetic stage of a type II diabetic rat model.

Authors:  L Yao; K Mizushige; T Noma; K Murakami; K Ohmori; H Matsuo
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

2.  Increased plasma lipoprotein (a) concentrations in Behcet's disease and its relation to vascular events.

Authors:  C Erem; T Uslu; O Deger; M Tosun; H Kavgaci
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

3.  Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials.

Authors:  Raban V Jeger; Philip Urban; Shannon M Harkness; Chi-Hong Tseng; Jean-Christophe Stauffer; Thierry H Lejemtel; Lynn A Sleeper; Matthias E Pfisterer; Judith S Hochman
Journal:  Acute Card Care       Date:  2011-01-18

Review 4.  Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper.

Authors:  Antoine Herpain; Stefaan Bouchez; Massimo Girardis; Fabio Guarracino; Johann Knotzer; Bruno Levy; Tobias Liebregts; Piero Pollesello; Sven-Erik Ricksten; Hynek Riha; Alain Rudiger; Fabio Sangalli
Journal:  J Cardiovasc Pharmacol       Date:  2019-01       Impact factor: 3.105
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.